Understanding LGBTQ Impacts Across AI – 2026 AI Report
Every stage of the AI lifecycle carries its own risks of bias and other harms. The report identifies those stages.
Read the original →Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.

Every stage of the AI lifecycle carries its own risks of bias and other harms. The report identifies those stages.
Read the original →A randomized trial of 400 pregnant women and new mothers found that Rosie, an AI chatbot, did not reduce anxiety or depression after 12 months compared with a book club.
Read the original →An AI-powered fitness concept aimed at helping people stay stronger and sharper as they age is gaining traction through local studios.
Read the original →A bibliometric analysis of literature from 2000 to 2025 charts the global emergence of artificial intelligence in wearable smart textiles. It also covers core collaborative networks and technical bottlenecks.
Read the original →Wong Ming Yin argued at Hong Kong's Optical Fair that AI glasses could shape global wearables. Battery life, comfort, privacy and practical uses remain hurdles.
Read the original →Thea AI is an AI-powered study aid designed to help students get better grades. The article reviews whether it works.
Read the original →NewJeans contracts reportedly omitted safeguards for minors. ADOR disputes concerns over teenage performers and AI-generated voice clones.
Read the original →A new Chinese Medical Journal review says AI and continuous glucose monitoring (CGM) are reshaping diabetes care through glucose prediction, intelligent insulin delivery, personalized nutrition and data-driven phenotyping. It describes a shift beyond traditional blood sugar tracking toward proactive, individualized management. The review notes ongoing challenges in cost, privacy and clinical integration.
Read the original →Google has announced research results for "AI-PPG-ACC-HTN," an AI system that detects hypertension using standard sensors in commercial smartwatches such as the Google Pixel Watch. These are the optical heart rate sensor and the accelerometer. The system analyzes pulse wave data from the optical sensor together with minute vibrations captured by the accelerometer.
Read the original →Korean drugmakers are betting on digital tools that monitor patients around the clock and flag disease risks.
Read the original →ScionxBio licenses its xRNA TERA platform to Sanofi. The platform targets chronic protein-deficiency diseases with AI-engineered mRNA that lasts weeks, not days.
Read the original →The Hong Kong Police will introduce AI facial recognition to its Smart View CCTV system this month. The aim is to detect crime and find missing people more accurately and quickly, especially high-risk missing elderly people with dementia.
Read the original →The FDA has issued a Request for Information (RFI) seeking input on AI in early-phase clinical trials. The RFI is consistent with recent FDA initiatives on leveraging AI technologies and improving early-phase clinical trial conduct.
Read the original →There is no evidence linking AI to mass layoffs. The technology has already "changed worker psychology".
Read the original →AI helps increase productivity but also exposes workers to invisible pressures such as unrecognized overtime, algorithmic monitoring and occupational burnout. These challenges call for innovation in human resource management and improvement of labor laws.
Read the original →On November 6, Korean drugmaker Hanmi Pharmaceutical announced the launch of "Epiday," a digital app for obesity patients. It helps them track treatment progress, manage nutrition and exercise, and share health data with their medical team.
Read the original →On November 6, 2026, TISI Inc., part of the TIS INTEC Group, announced a move involving Taiwan's FaceHeart Inc. FaceHeart has AI technology that measures vital data such as heart rate without contact, using camera images from devices such as smartphones.
Read the original →Efforts are spreading to analyze data from continuous glucose monitors (CGM) with AI. CGMs estimate blood sugar by measuring glucose in interstitial fluid with a thin needle. The technology is still at the research stage, and the reporter tried a currently available service, including a patient lifestyle guidance support service that The Farge (Tokyo, Chiyoda) provides to medical institutions.
Read the original →Deputy government spokesperson Padarat said on November 6 that the Ministry of Higher Education, Science, Research and Innovation is promoting a health economy strategy using science, technology and advanced innovation. The plan is to advance nationwide practical use of medical AI and precision medicine and develop Thailand into a health and longevity hub for Asia.
Read the original →